Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes
Clinical trial NCT02081014 · COMPLETED
Trial details
- NCT number
- NCT02081014
- Sponsor
- Xeris Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-11-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.